info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > JAK
JAK
Cat.No. Product Name Information Area
T3673 Mollugin Mollugin may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by b... Others
T6933 Peficitinib (ASP015K, JNJ-54781532) Peficitinib (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3. Others
T6914 Oclacitinib Oclacitinib is a novel inhibitor of JAK family members with IC50 ranging from 10 to 9... Others
T6838 FLLL32 FLLL32 is a potent JAK2/STAT3 inhibitor with IC50 of <5 μM. Others
T6790 BMS-911543 BMS-911543 is a potent and selective inhibitor of JAK2 with IC50 of 1.1?nM, ~350-, 75... Others
T3620 Solcitinibnew Solcitinib, also known as GSK2586184 or GLPG0778, is a Janus kinase 1 (JAK1) inhibito... Immunology
T3398 Icaritinnew Icaritin has hormone regulation activity and cardiovascular function improvement acti... Cancer
T6156 S-Ruxolitinib (INCB018424) S-Ruxolitinib is the chirality of INCB018424, which is the first potent, selective, J... Cancer
T6124 Mubritinib (TAK 165)new Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM; no activi... Cancer
T6104 Cerdulatinib hydrochloride Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor... Cancer
T6020 Pacritinib (SB1518) Pacritinib (SB1518) is a potent and selective inhibitor of Janus Kinase 2 (JAK2) and ... Cancer
T3080 Pyridone 6 Pyridone 6(CMP 6) is a potent and selective inhibitor of JAK1 (IC50=15 nM, murine JAK... Cancer
T3076 GLPG0634 analogue GLPG0634 analogue is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, an... Cancer
T3072 XL019 XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, exhibiting >50-fo... Cancer
T3069 AZD1480 AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM in a cell-free... Cancer
T3068 AT9283 AT9283 is a potent JAK2/3 inhibitor with IC50 of 1.2 nM/1.1 nM in cell-free assays; a... Cancer
T3065 TG101209 TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET... Cancer
T3043 Ruxolitinib phosphate Ruxolitinib phosphate(INCB018424 phosphate) is the first potent, selective, JAK1/2 in... Cancer
T3042 NSC 42834 NSC 42834(JAK2 Inhibitor V, Z3), a novel specific inhibitor of Jak2, inhibits Jak2-V6... Cancer
T2853 Curcumol Curcumol is a pure monomer isolated from Rhizoma Curcumaeis with antitumor activities... Cancer
T2709 TAK901 TAK-901 is a novel inhibitor of Aurora A/B with IC50 of 21 nM/15 nM. It is not a pote... Cancer
T2653 SB1317 SB1317/TG02 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 ... Cancer
T2638 Gandotinib (LY2784544) LY2784544(gandotinib) is a potent JAK2 inhibitor with IC50 of 3 nM, effective in JAK2... Cancer
T2636 Decernotinib(VX-509) Decernotinib(VX-509; VRT-831509) is a potent and selective Janus kinase 3 (JAK3) inhi... Cancer
T2600 AG-490 AG-490 (Tyrphostin AG 490) is an inhibitor of EGFR with IC50 of 0.1 μM, 135-fold more... Other
T2487 Cerdulatinib Cerdulatinib(PRT-062070; PRT2070) is an novel oral dual Syk/JAK inhibitor. Cancer
T2485 Baricitinib Baricitinib (LY3009104, INCB028050) is a selective JAK1 and JAK2 inhibitor with IC50 ... Cancer
T2460 ZM 39923 hydrochloride ZM 39923 hydrochloride is an JAK1/3 inhibitor with pIC50 of 4.4/7.1, almost no activi... Other
T2426 CEP-33779 CEP-33779 is a novel selective JAK2 inhibitor. Other
T2398 Tofacitinib citrate Tofacitinib citrate (CP-690550 citrate) is a novel inhibitor of JAK3 with IC50 of 1 n... Cancer
1